The Early Effect of Carotid Artery Stenting on Antioxidant Capacity and Oxidative Stress in Patients with Carotid Artery Stenosis

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Michalak, Slawomir ^a   Ambrosius, Wojciech ^a   Wysocka, Ewa ^a   Dziarmaga, Mieczyslaw ^a   Juszkat, Robert ^a   Wykretowicz, Andrzej ^a   Kozubski, Wojciech ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

SPECTROPHOTOMETRY; STENTS;

CAROTID ARTERY STENOSIS; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMIES; ENDOVASCULAR PROCEDURES; MYOCARDIAL INFARCTION; NEUROLOGICAL DEFICIT; NON-ENZYMATIC ANTIOXIDANTS; SPECTRO-PHOTOMETRIC METHOD;

ANTIOXIDANTS;

ALKADIENE; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; THIOL GROUP; TRIACYLGLYCEROL; ANTIOXIDANT; CARBOXYLESTERASE; POLYENE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CARDIAC PATIENT; CAROTID ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; NEUROLOGIC DISEASE; OXIDATIVE STRESS; SELF EXPANDING NITINOL STENT; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL; CAROTID ARTERY; COHORT ANALYSIS; DEMOGRAPHY; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; STENT;

ANTIOXIDANTS; DIAGNOSIS; DISEASES; MEDICINE;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CAROTID ARTERIES; CAROTID STENOSIS; COHORT STUDIES; DEMOGRAPHY; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; POLYENES; STENTS;

EID: 85008893443     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1789596     Document Type: Article

References (60)

1. J. Golledge, R. M. Greenhalgh, and A. H. Davies, "The symptomatic carotid plaque," Stroke, vol. 31, no. 3, pp. 774-781, 2000.
2. P. M. Rothwell, M. Eliasziw, S. A. Gutnikov et al., "Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis," The Lancet, vol. 361, no. 9352, pp. 107-116, 2003.
3. T. G. Brott, R. W. Hobson II, G. Howard et al., "Stenting versus endarterectomy for treatment of carotid-artery stenosis," New England Journal of Medicine, vol. 363, no. 1, pp. 11-23, 2010.
4. J. F. Meschia, L. N. Hopkins, I. Altafullah et al., "Time from symptoms to carotid endarterectomy or stenting and perioperative risk," Stroke, vol. 46, no. 12, pp. 3540-3542, 2015.
5. J. E. Jung, G. S. Kim, H. Chen et al., "Reperfusion and neurovascular dysfunction in stroke: frombasic mechanisms to potential strategies for neuroprotection," Molecular Neurobiology, vol. 41, no. 2-3, pp. 172-179, 2010.
6. A. Angelini, A. Visona, F. Calabrese et al., "Time course of apoptosis and proliferation in vascular smoothmuscle cells after balloon angioplasty," Basic and Applied Myology, vol. 12, pp. 33-42, 2002.
7. C. V. Serrano Jr., J. A. F. Ramires, M. Venturinelli et al., "Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty," Journal of the American College of Cardiology, vol. 29, no. 6, pp. 1276-1283, 1997.
8. C. Gomez, L. Martinez, A. Mesa et al., "Oxidative stress induces early-onset apoptosis of vascular smooth muscle cells and neointima formation in response to injury," Bioscience Reports, vol. 35, no. 4, Article ID e00227, 2015.
9. T. Adachi, R. M. Weisbrod, D. R. Pimentel et al., "S-glutathiolation by peroxynitrite activates SERCAduring arterial relaxation by nitric oxide," Nature Medicine, vol. 10, no. 11, pp. 1200-1207, 2004.
10. S. R. Thomas, P. K. Witting, and G. R. Drummond, "Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities," Antioxidants and Redox Signaling, vol. 10, no. 10, pp. 1713-1765, 2008.
11. A. D. Watson, J. A. Berliner, S. Y. Hama et al., "Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein," The Journal of Clinical Investigation, vol. 96, no. 6, pp. 2882-2891, 1995.
12. C. J. Ng, D. J. Wadleigh, A. Gangopadhyay et al., "Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein," Journal of Biological Chemistry, vol. 276, no. 48, pp. 44444-44449, 2001.
13. W. N. Aldridge, "Serum esterases. 1. Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination," The Biochemical journal, vol. 53, no. 1, pp. 110-117, 1953.
14. K. Augustinsson, "Multiple forms of esterase in vertebrate blood plasma," Annals of the New York Academy of Sciences, vol. 94, no. 3, pp. 844-860, 1961.
15. H. W. Eckerson, C. M. Wyte, and B. N. La Du, "The human serumparaoxonase/arylesterase polymorphism," The American Journal of Human Genetics, vol. 35, no. 6, pp. 1126-1138, 1983.
16. S. Michalak, R. Kazmierski, A. Hellmann et al., "Serumparaoxonase/arylesterase activity affects outcome in ischemic stroke patients," Cerebrovascular Diseases, vol. 32, no. 2, pp. 124-132, 2011.
17. P. Di Simplicio, S. Frosali, R. Priora et al., "Biochemical and biological aspects of protein thiolation in cells and plasma," Antioxidants & Redox Signaling, vol. 7, no. 7-8, pp. 951-963, 2005.
18. M. Musumeci, S. Sotgiu, S. Persichilli et al., "Role of SH levels and markers of immune response in the stroke," Disease Markers, vol. 35, no. 3, pp. 141-147, 2013.
19. R. J. Traystman, J. R. Kirsch, and R. C. Koehler, "Oxygen radical mechanisms of brain injury following ischemia and reperfusion," Journal of Applied Physiology, vol. 71, no. 4, pp. 1185-1195, 1991.
20. L. S. Bir, S. Demir, S. Rota, and M. Köseoǧlu, "Increased serum malondialdehyde levels in chronic stage of ischemic stroke," Tohoku Journal of Experimental Medicine, vol. 208, no. 1, pp. 33-39, 2005.
21. A. Ozkul, A. Akyol, C. Yenisey, E. Arpaci, N. Kiylioglu, and C. Tataroglu, "Oxidative stress in acute ischemic stroke," Journal of Clinical Neuroscience, vol. 14, no. 11, pp. 1062-1066, 2007.
22. M. C. Polidori, A. Cherubini, W. Stahl, U. Senin, H. Sies, and P. Mecocci, "Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome," Free Radical Research, vol. 36, no. 3, pp. 265-268, 2002.
23. E. V. Silina, S. A. Rumiantseva, S. B. Bolevich, and N. I. Men'shova, "[Course of free radical processes and prognosis of ischemic and hemorrhagic stroke]," Zhurnal Nevrologii I Psikhiatrii Imeni S.s. Korsakova, vol. 111, no. 12, pp. 36-42, 2011.
24. M. Aviram, M. Rosenblat, C. L. Bisgaier, R. S. Newton, S. L. Primo-Parmo, and B. N. La Du, "Paraoxonase inhibits highdensity lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase," Journal of Clinical Investigation, vol. 101, no. 8, pp. 1581-1590, 1998.
25. K. N. Gan, A. Smolen, H. W. Eckerson, and B. N. La Du, "Purification of human serum paraoxonase/arylesterase," Drug Metabolism and Disposition, vol. 19, no. 1, pp. 100-106, 1991.
26. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
27. R. O. Recknagel and E. A. Glende Jr., "Spectrophotometric detection of lipid conjugated dienes," Methods in Enzymology, vol. 105, pp. 331-337, 1984.
28. G. L. Ellman, "Tissue sulfhydryl groups," Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70-77, 1959.
29. W. Whiteley, C. Jackson, S. Lewis et al., "Inflammatorymarkers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6," PLo SMedicine, vol. 6, no. 9, Article ID e1000145, 2009.
30. J. Kotur-Stevuljevic, N. Bogavac-Stanojevic, Z. Jelic-Ivanovic et al., "Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients," Atherosclerosis, vol. 241, no. 1, pp. 192-198, 2015.
31. G. Ferretti, T. Bacchetti, S. Masciangelo et al., "Lipid peroxidation in stroke patients," Clinical Chemistry and Laboratory Medicine, vol. 46, no. 1, pp. 113-117, 2008.
32. G. Ozsarlak-Sozer, Z. Kerry, G. Gokce, I. Oran, and Z. Topcu, "Oxidative stress in relation to telomere length maintenance in vascular smooth muscle cells following balloon angioplasty," Journal of Physiology and Biochemistry, vol. 67, no. 1, pp. 35-42, 2011.
33. R. Kawamotoa, A. Yamashitab, K. Nishihiraa et al., "Different inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbits," Pathology, Research and Practice, vol. 202, no. 6, pp. 447-456, 2006.
34. A. Devarajan, N. Bourquard, S. Hama et al., "Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis," Antioxidants & Redox Signaling, vol. 14, no. 3, pp. 341-351, 2011.
35. G. Díaz-Araya, D. Nettle, P. Castro et al., "Oxidative stress after reperfusion with primary coronary angioplasty: lack of effect of glucose-insulin-potassium infusion," Critical Care Medicine, vol. 30, no. 2, pp. 417-421, 2002.
36. K. R. Feingold, R. A. Memon, A. H. Moser, and C. Grunfeld, "Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response," Atherosclerosis, vol. 139, no. 2, pp. 307-315, 1998.
37. C. C. Hedrick, K. Hassan, G. P. Hough et al., "Short-termfeeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 8, pp. 1946-1952, 2000.
38. L. G. Costa, T. B. Cole, G. P. Jarvik, and C. E. Furlong, "Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism," Annual Review of Medicine, vol. 54, pp. 371-392, 2003.
39. B. Mackness, P. N. Durrington, B. Abuashia, A. J. M. Boulton, and M. I. Mackness, "Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy," Clinical Science, vol. 98, no. 3, pp. 355-363, 2000.
40. C. A. Abbott, M. I. Mackness, S. Kumar, A. J. Boulton, and P. N. Durrington, "Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 11, pp. 1812-1818, 1995.
41. B. MacKness, M. I. MacKness, S. Arrol et al., "Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus," Atherosclerosis, vol. 139, no. 2, pp. 341-349, 1998.
42. S. D. Nguyen and D.-E. Sok, "Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position," Biochimica et Biophysica Acta (BBA)-Biomembranes, vol. 1758, no. 4, pp. 499-508, 2006.
43. Y. Suzuki, A. Fausto, K. A. Hruska, and L.V. Avioli, "Stimulation of phosphatidylcholine biosynthesis in diabetic hypertrophic kidneys," Endocrinology, vol. 120, no. 2, pp. 595-601, 1987.
44. E. L. Donovan, S. M. Pettine, M. S. Hickey, K. L. Hamilton, and B. F. Miller, "Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean," Diabetology and Metabolic Syndrome, vol. 5, article 24, 2013.
45. M. Seigneur, G. Freyburger, H. Gin et al., "Serum fatty acid profiles in type I and type II diabetes: metabolic alterations of fatty acids of the main serum lipids," Diabetes Research and Clinical Practice, vol. 23, no. 3, pp. 169-177, 1994.
46. S. Deakin, X. Moren, and R. W. James, "Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells," Atherosclerosis, vol. 179, no. 1, pp. 17-25, 2005.
47. H. G. Davies, R. J. Richter, M. Keifer, C. A. Broomfield, J. Sowalla, and C. E. Furlong, "The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin," Nature genetics, vol. 14, no. 3, pp. 334-336, 1996.
48. C. H. Park, S. D. Nguyen, M. R. Kim, T.-S. Jeong, and D.-E. Sok, "Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound," Lipids, vol. 41, no. 4, pp. 371-380, 2006.
49. D. Mannheim, J. Herrmann, D. Versari et al., "Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques," Stroke, vol. 39, no. 5, pp. 1448-1455, 2008.
50. M. Aviram, S. Billecke, R. Sorenson et al., "Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities. Selective action of human paraoxonase allozymes Q and R," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 10, pp. 1617-1624, 1998.
51. B. Voetsch, K. S. Benke, C. I. Panhuysen, B. P. Damasceno, and J. Loscalzo, "The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults," Archives of Neurology, vol. 61, no. 3, pp. 351-356, 2004.
52. D. Giustarini, I. Dalle-Donne, S. Lorenzini, A. Milzani, and R. Rossi, "Age-related influence on thiol, disulfide, and proteinmixed disulfide levels in human plasma," Journals of Gerontology, vol. 61A, no. 10, pp. 1030-1038, 2006.
53. J. R. Roede, K. Uppal, Y. Liang, D. E. L. Promislow, L. M. Wachtman, and D. P. Jones, "Characterization of plasma thiol redox potential in a commonmarmosetmodel of aging," Redox Biology, vol. 1, no. 1, pp. 387-393, 2013.
54. A. Waśkiewicz, E. Sygnowska, and G. Broda, "Homocysteine concentration and the risk of death in the adult Polish population," Kardiologia Polska, vol. 70, no. 9, pp. 897-902, 2012.
55. K. S. McCully, "The active site of oxidative phosphorylation and the origin of hyperhomocysteinemia in aging and dementia," Annals of Clinical and Laboratory Science, vol. 45, no. 2, pp. 222-225, 2015.
56. R. Murín, A. Drgová, P. Kaplán, D. Dobrota, and J. Lehotský, "Ischemia/reperfusion-induced oxidative stress causes structural changes of brain membrane proteins and lipids," General Physiology and Biophysics, vol. 20, no. 4, pp. 431-438, 2001.
57. B. S. Allen, M. Castellá, G. D. Buckberg, and Z. Tan, "Conditioned blood reperfusionmarkedly enhances neurologic recovery after prolonged cerebral ischemia," Journal of Thoracic and Cardiovascular Surgery, vol. 126, no. 6, pp. 1851-1858, 2003.
58. A. Buffon, S. A. Santini, V. Ramazzotti et al., "Large, sustained cardiac lipid peroxidation and reduced antioxidant capacity in the coronary circulation after brief episodes of myocardial ischemia," Journal of the American College of Cardiology, vol. 35, no. 3, pp. 633-639, 2000.
59. D. Çiçek, L. Tamer, H. Pekdemir et al., "Coronary angioplasty induced oxidative stress and its relation with metoprolol use and plasma homocysteine levels," The Anatolian Journal of Cardiology, vol. 6, no. 4, pp. 308-313, 2006.
60. 2-isoprostane formation: evidence for in vivo oxidative stress during PTCA," Journal of the American College of Cardiology, vol. 37, no. 1, pp. 76-80, 2001.